Literature DB >> 12417417

Hereditary multiple exostoses and heparan sulfate polymerization.

Beverly M Zak1, Brett E Crawford, Jeffrey D Esko.   

Abstract

Hereditary multiple exostoses (HME, OMIM 133700, 133701) results from mutations in EXT1 and EXT2, genes encoding the copolymerase responsible for heparan sulfate (HS) biosynthesis. Members of this multigene family share the ability to transfer N-acetylglucosamine to a variety of oligosaccharide acceptors. EXT1 and EXT2 encode the copolymerase, whereas the roles of the other EXT family members (EXTL1, L2, and L3) are less clearly defined. Here, we provide an overview of HME, the EXT family of proteins, and possible models for the relationship of altered HS biosynthesis to the ectopic bone growth characteristic of the disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12417417     DOI: 10.1016/s0304-4165(02)00402-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  51 in total

1.  A mouse model of chondrocyte-specific somatic mutation reveals a role for Ext1 loss of heterozygosity in multiple hereditary exostoses.

Authors:  Kazu Matsumoto; Fumitoshi Irie; Susan Mackem; Yu Yamaguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

Review 2.  Planar cell polarity signaling in craniofacial development.

Authors:  Jacek Topczewski; Rodney M Dale; Barbara E Sisson
Journal:  Organogenesis       Date:  2011-10-01       Impact factor: 2.500

3.  Compound heterozygous loss of Ext1 and Ext2 is sufficient for formation of multiple exostoses in mouse ribs and long bones.

Authors:  Beverly M Zak; Manuela Schuksz; Eiki Koyama; Christina Mundy; Dan E Wells; Yu Yamaguchi; Maurizio Pacifici; Jeffrey D Esko
Journal:  Bone       Date:  2011-02-15       Impact factor: 4.398

4.  Of brain and bone: the unusual case of Dr. A.

Authors:  J Narvid; M L Gorno-Tempini; A Slavotinek; S J Dearmond; Y H Cha; B L Miller; K Rankin
Journal:  Neurocase       Date:  2009-06       Impact factor: 0.881

5.  Increase of exostosin 1 in plasma as a potential biomarker for opisthorchiasis-associated cholangiocarcinoma.

Authors:  Jarinya Khoontawad; Nuttanan Hongsrichan; Yaovalux Chamgramol; Porntip Pinlaor; Chaisiri Wongkham; Puangrat Yongvanit; Chawalit Pairojkul; Narong Khuntikeo; Sittiruk Roytrakul; Thidarut Boonmars; Somchai Pinlaor
Journal:  Tumour Biol       Date:  2013-09-10

6.  Sugar-free frosting, a homolog of SAD kinase, drives neural-specific glycan expression in the Drosophila embryo.

Authors:  Sarah Baas; Mary Sharrow; Varshika Kotu; Meg Middleton; Khoi Nguyen; Heather Flanagan-Steet; Kazuhiro Aoki; Michael Tiemeyer
Journal:  Development       Date:  2011-02       Impact factor: 6.868

7.  Expression of genes encoding for proteins involved in heparan sulphate and chondroitin sulphate chain synthesis and modification in normal and malignant plasma cells.

Authors:  Caroline Bret; Dirk Hose; Thierry Reme; Anne-Catherine Sprynski; Karène Mahtouk; Jean-François Schved; Philippe Quittet; Jean-François Rossi; Hartmut Goldschmidt; Bernard Klein
Journal:  Br J Haematol       Date:  2009-03-02       Impact factor: 6.998

Review 8.  Human genetic disorders caused by mutations in genes encoding biosynthetic enzymes for sulfated glycosaminoglycans.

Authors:  Shuji Mizumoto; Shiro Ikegawa; Kazuyuki Sugahara
Journal:  J Biol Chem       Date:  2013-03-01       Impact factor: 5.157

9.  Multiple osteochondromas: clinicopathological and genetic spectrum and suggestions for clinical management.

Authors:  Liesbeth Hameetman; Judith Vmg Bovée; Antonie Hm Taminiau; Herman M Kroon; Pancras Cw Hogendoorn
Journal:  Hered Cancer Clin Pract       Date:  2004-11-15       Impact factor: 2.857

10.  Impairment of glycosaminoglycan synthesis in mucopolysaccharidosis type IIIA cells by using siRNA: a potential therapeutic approach for Sanfilippo disease.

Authors:  Dariusz Dziedzic; Grzegorz Wegrzyn; Joanna Jakóbkiewicz-Banecka
Journal:  Eur J Hum Genet       Date:  2009-08-19       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.